GSK Discovery Fast Track Boston (DFT)
The GSK Discovery Fast Track Boston (DFT) Challenge opened on Monday, 25 April 2016. We hope that Principal Investigators from your institution will consider applying for the DFT Boston Challenge, which is described at http://openinnovation.gsk.com/challenge-bos/.
Similar to previous Discovery Fast Track Challenges, this Boston Challenge offers Principal Investigators (PIs) the opportunity to collaborate with GSK in accelerating the development of their target-based concept into a novel medicine. The 2016 DFT Boston Challenge concentrates on establishing collaborations between PIs from the greater Boston area and GSK scientists from Discovery Partnerships with Academia and the DNA-Encoded Library Technology (ELT) Team based in Waltham, Massachusetts. In these collaborations, PIs or their delegate will have the option of working directly with our ELT scientists in developing and performing an ELT screen to identify novel compounds that bind to their protein target of interest. The current GSK ELT compound collection spans 94 different libraries that, when combined, contain greater than 1 trillion unique compounds, each tagged with its own unique DNA barcode.